We conducted a double-blind, placebo-controlled trial of oral azidothymidine (AZT) in 282 patients with the acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. Although significant clinical benefit was documented (N Engl J Med 1987; 317:185-91), serious adverse reactions, particularly bone marrow suppression, were observed. Nausea, myalgia, insomnia, and severe headaches were reported more frequently by recipients of AZT; macrocytosis developed within weeks in most of the AZT group. Anemia with hemoglobin levels below 7.5 g per deciliter developed in 24 percent of AZT recipients and 4 percent of placebo recipients (P less than 0.001). Twenty-one percent of AZT recipients and 4 percent of placebo recipients required multiple red-cell transfusions (P less than 0.001). Neutropenia (less than 500 cells per cubic millimeter) occurred in 16 percent of AZT recipients, as compared with 2 percent of placebo recipients (P less than 0.001). Subjects who entered the study with low CD4 lymphocyte counts, low serum vitamin B12 levels, anemia, or low neutrophil counts were more likely to have hematologic toxic effects. Concurrent use of acetaminophen was also associated with a higher frequency of hematologic toxicity. Although a subset of patients tolerated AZT for an extended period with few toxic effects, the drug should be administered with caution because of its toxicity and the limited experience with it to date.
This article has been cited by other articles:
Forna, F., Moore, D., Mermin, J., Brooks, J. T., Were, W., Buchacz, K., Campbell, J. D., Downing, R., Borkowf, C. B., Weidle, P. J.
(2009). Hematologic Changes Associated With Zidovudine Following Single-Drug Substitution From Stavudine in a Home-Based AIDS Care Program in Rural Uganda. J Int Assoc Physicians AIDS Care (Chic Ill)
8: 128-138
[Abstract]
Fang, J.-L., McGarrity, L. J., Beland, F. A.
(2009). Interference of cell cycle progression by zidovudine and lamivudine in NIH 3T3 cells. Mutagenesis
24: 133-141
[Abstract][Full Text]
Hurwitz, S. J., Asif, G., Kivel, N. M., Schinazi, R. F.
(2008). Development of an Optimized Dose for Coformulation of Zidovudine with Drugs That Select for the K65R Mutation Using a Population Pharmacokinetic and Enzyme Kinetic Simulation Model. Antimicrob. Agents Chemother.
52: 4241-4250
[Abstract][Full Text]
Lafaurie, M., Collin, F., Bentata, M., Garre, M., Leport, C., Levy, Y., Goujard, C., Chene, G., Molina, J.-M., on behalf of the ALIZE Study Group,
(2008). Switch from zidovudine- to non-zidovudine-containing regimens is associated with modest haematological improvement and no obvious clinical benefit: a substudy of the ANRS 099 ALIZE trial. J Antimicrob Chemother
62: 1122-1129
[Abstract][Full Text]
Anderson, P. L., King, T., Zheng, J.-H., MaWhinney, S.
(2008). Cytokine and sex hormone effects on zidovudine- and lamivudine-triphosphate concentrations in vitro. J Antimicrob Chemother
62: 738-745
[Abstract][Full Text]
Bridges, E. G., Selden, J. R., Luo, S.
(2008). Nonclinical Safety Profile of Telbivudine, a Novel Potent Antiviral Agent for Treatment of Hepatitis B. Antimicrob. Agents Chemother.
52: 2521-2528
[Abstract][Full Text]
Asif, G., Hurwitz, S. J., Obikhod, A., Delinsky, D., Narayanasamy, J., Chu, C. K., McClure, H. M., Schinazi, R. F.
(2007). Pharmacokinetics of the Anti-Human Immunodeficiency Virus Agent 1-({beta}-D-Dioxolane)Thymine in Rhesus Monkeys. Antimicrob. Agents Chemother.
51: 2424-2429
[Abstract][Full Text]
Cadranel, J, Garfield, D, Lavole, A, Wislez, M, Milleron, B, Mayaud, C
(2006). Lung cancer in HIV infected patients: facts, questions and challenges.. Thorax
61: 1000-1008
[Abstract][Full Text]
Kim, A., Dadgostar, H., Holland, G. N., Wenby, R., Yu, F., Terry, B. G., Meiselman, H. J.
(2006). Hemorheologic Abnormalities Associated with HIV Infection: Altered Erythrocyte Aggregation and Deformability.. IOVS
47: 3927-3932
[Abstract][Full Text]
Levine, A. M., Karim, R., Mack, W., Gravink, D. J., Anastos, K., Young, M., Cohen, M., Newman, M., Augenbraun, M., Gange, S., Watts, D. H.
(2006). Neutropenia in Human Immunodeficiency Virus Infection: Data From the Women's Interagency HIV Study.. Arch Intern Med
166: 405-410
[Abstract][Full Text]
Feola, D. J., Garvy, B. A.
(2006). Combination Exposure to Zidovudine plus Sulfamethoxazole-Trimethoprim Diminishes B-Lymphocyte Immune Responses to Pneumocystis murina Infection in Healthy Mice. CVI
13: 193-201
[Abstract][Full Text]
Tefferi, A., Hanson, C. A., Inwards, D. J.
(2005). How to Interpret and Pursue an Abnormal Complete Blood Cell Count in Adults. Mayo Clin Proc.
80: 923-936
[Abstract]
Reid, S., Dwyer, J.
(2005). Insomnia in HIV Infection: A Systematic Review of Prevalence, Correlates, and Management. Psychosom. Med.
67: 260-269
[Abstract][Full Text]
Cade, W T., Peralta, L., Keyser, R. E
(2004). Aerobic Exercise Dysfunction in Human Immunodeficiency Virus: A Potential Link to Physical Disability. ptjournal
84: 655-664
[Full Text]
Dutschman, G. E., Grill, S. P., Gullen, E. A., Haraguchi, K., Takeda, S., Tanaka, H., Baba, M., Cheng, Y.-C.
(2004). Novel 4'-Substituted Stavudine Analog with Improved Anti-Human Immunodeficiency Virus Activity and Decreased Cytotoxicity. Antimicrob. Agents Chemother.
48: 1640-1646
[Abstract][Full Text]
Lewis, L D, Amin, S, Civin, C I, Lietman, P S
(2004). Ex vivo zidovudine (AZT) treatment of CD34+ bone marrow progenitors causes decreased steady state mitochondrial DNA (mtDNA) and increased lactate production. Hum Exp Toxicol
23: 173-185
[Abstract]
Volberding, P. A., Baker, K. R., Levine, A. M.
(2003). Human Immunodeficiency Virus Hematology. ASH Education Book
2003: 294-313
[Abstract][Full Text]
D'Cruz, O. J., Uckun, F. M.
(2002). Pre-clinical safety evaluation of novel nucleoside analogue-based dual-function microbicides (WHI-05 and WHI-07). J Antimicrob Chemother
50: 793-803
[Abstract][Full Text]
Demas, P. A., Webber, M. P., Schoenbaum, E. E., Weedon, J., McWayne, J., Enriquez, E., Bamji, M., Lambert, G., Thea, D. M.
(2002). Maternal Adherence to the Zidovudine Regimen for HIV-Exposed Infants to Prevent HIV Infection: A Preliminary Study. Pediatrics
110: e35-35
[Abstract][Full Text]
Jordan, R., Gold, L., Cummins, C., Hyde, C.
(2002). Systematic review and meta-analysis of evidence for increasing numbers of drugs in antiretroviral combination therapy. BMJ
324: 757-757
[Abstract][Full Text]
Nielsen, S. D., Jeppesen, D. L., Kolte, L., Clark, D. R., Sorensen, T. U., Dreves, A.-M., Ersboll, A. K., Ryder, L. P., Valerius, N. H., Nielsen, J. O.
(2001). Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts. Blood
98: 398-404
[Abstract][Full Text]
D'Cruz, O. J., Uckun, F. M.
(2001). Short-Term (13-week) Toxicity Study of 5-Bromo-6-methoxy-5,6- dihydro-3'-azidothymidine-5'-(p-bromophenyl) Methoxyalaninyl Phosphate (WHI-07), a Novel Anti-HIV and Contraceptive Agent, in B6C3F1 Mice. Toxicol Sci
60: 373-378
[Abstract][Full Text]
Wada, S., Tsuda, M., Sekine, T., Cha, S. H., Kimura, M., Kanai, Y., Endou, H.
(2000). Rat Multispecific Organic Anion Transporter 1 (rOAT1) Transports Zidovudine, Acyclovir, and Other Antiviral Nucleoside Analogs. J. Pharmacol. Exp. Ther.
294: 844-849
[Abstract][Full Text]
Smith, P. F., Forrest, A., Ballow, C. H., Martin, D. E., Proulx, L.
(2000). Absolute Bioavailability and Disposition of (-) and (+) 2'-Deoxy- 3'-Oxa-4'-Thiocytidine (dOTC) following Single Intravenous and Oral Doses of Racemic dOTC in Humans. Antimicrob. Agents Chemother.
44: 1609-1615
[Abstract][Full Text]
Freund, Y. R., Dousman, L., MacGregor, J. T., Mohagheghpour, N.
(2000). Oral Treatment with Trimethoprim-Sulfamethoxazole and Zidovudine Suppresses Murine Accessory Cell-Dependent Immune Responses. Toxicol Sci
55: 335-342
[Abstract][Full Text]
Meng, Q., Su, T., Olivero, O. A., Poirier, M. C., Shi, X., Ding, X., Walker, V. E.
(2000). Relationships between DNA Incorporation, Mutant Frequency, and Loss of Heterozygosity at the TK Locus in Human Lymphoblastoid Cells Exposed to 3'-Azido-3'-deoxythymidine. Toxicol Sci
54: 322-329
[Abstract][Full Text]
Graham III, C. B., Wippold II, F. J., Pilgram, T. K., Fisher, E. J., Smoker, W. R. K.
(2000). Screening CT of the Brain Determined by CD4 Count in HIV-Positive Patients Presenting with Headache. Am. J. Neuroradiol.
21: 451-454
[Abstract][Full Text]
Franck, L. S., Johnson, L. M., Lee, K., Hepner, C., Lambert, L., Passeri, M., Manio, E., Dorenbaum, A., Wara, D.
(1999). Sleep Disturbances in Children With Human Immunodeficiency Virus Infection. Pediatrics
104: 62e-62
[Abstract][Full Text]
Difalco, M. R., Dufresne, L., Congote, L. F.
(1998). Efficacy of an Insulin-Like Growth Factor-Interleukin-3 Fusion Protein in Reversing the Hematopoietic Toxicity Associated with Azidothymidine in Mice. J. Pharmacol. Exp. Ther.
284: 449-454
[Abstract][Full Text]
Chang, M., Sood, V. K., Kloosterman, D. A., Hauer, M. J., Fagerness, P. E., Sanders, P. E., Vrbanac, J. J.
(1997). Identification of the Metabolites of the HIV-1 Reverse Transcriptase Inhibitor Delavirdine in Monkeys. Drug Metab. Dispos.
25: 814-827
[Abstract][Full Text]
Chang, M., Sood, V. K., Wilson, G. J., Kloosterman, D. A., Sanders, P. E., Hauer, M. J., Zhang, W., Branstetter, D. G.
(1997). Metabolism of the HIV-1 Reverse Transcriptase Inhibitor Delavirdine In Mice. Drug Metab. Dispos.
25: 828-839
[Abstract][Full Text]
McDonald, C. K., Kuritzkes, D. R.
(1997). Human Immunodeficiency Virus Type 1 Protease Inhibitors. Arch Intern Med
157: 951-959
[Abstract]
Esnouf, R. M., Ren, J., Hopkins, A. L., Ross, C. K., Jones, E. Y., Stammers, D. K., Stuart, D. I.
(1997). Unique features in the structure of the complex between HIV-1 reverse transcriptase and the bis(heteroaryl)piperazine (BHAP) U-90152 explain resistance mutations for this nonnucleoside inhibitor. Proc. Natl. Acad. Sci. USA
94: 3984-3989
[Abstract][Full Text]
Patterson, T. A., Binienda, Z. K., Lipe, G. W., Gillam, M. P., Slikker, W. Jr., Sandberg, J. A.
(1997). Transplacental Pharmacokinetics and Fetal Distribution of Azidothymidine, Its Glucuronide, and Phosphorylated Metabolites in Late-Term Rhesus Macaques after Maternal Infusion. Drug Metab. Dispos.
25: 453-459
[Abstract][Full Text]
Hentosh, P., Tibudan, M.
(1997). 2-Chloro-2'-deoxyadenosine, an Antileukemic Drug, Has an Early Effect on Cellular Mitochondrial Function. Mol. Pharmacol.
51: 613-619
[Abstract][Full Text]
Chang, M., Sood, V. K., Wilson, G. J., Kloosterman, D. A., Sanders, P. E., Hauer, M. J., Fagerness, P. E.
(1997). Metabolism of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Delavirdine in Rats. Drug Metab. Dispos.
25: 228-242
[Abstract][Full Text]
Collier, A. C., Coombs, R. W., Schoenfeld, D. A., Bassett, R. L., Timpone, J., Baruch, A., Jones, M., Facey, K., Whitacre, C., McAuliffe, V. J., Friedman, H. M., Merigan, T. C., Reichman, R. C., Hooper, C., Corey, L., The AIDS Clinical Trials Group,
(1996). Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine. NEJM
334: 1011-1018
[Abstract][Full Text]
Moore, R. D., Keruly, J. C., Chaisson, R. E.
(1995). Neutropenia and Bacterial Infection in Acquired Immunodeficiency Syndrome. Arch Intern Med
155: 1965-1970
[Abstract]
Czachor, J. S., Gleckman, R. A.
(1995). Selective Causes of Fever in Adult Human Immunodeficiency Virus--Infected Patients Relative to CD4+ Cell Counts. Arch Fam Med
4: 879-884
[Abstract]
Dolin, R., Amato, D. A., Fischl, M. A., Pettinelli, C., Beltangady, M., Liou, S.-h., Brown, M. J., Cross, A. P., Hirsch, M. S., Hardy, W. D., Mildvan, D., Blair, D. C., Powderly, W. G., Para, M. F., Fife, K. H., Steigbigel, R. T., Smaldone, L., AIDS Clinical Trials Group, , National Institute of Allergy and Infectious Disea, , National Institutes of Health, , Bristol-Myers Squibb, , Crumpacker, C. S., Cooley, T., Mitsuyaso, R. T., John, R., Sanders, C., Reitman, D., Hewitt, R., Reichman, R. C., Gelb, L. D., McGuire, M. L., Jones, M., Neidig, J. L., Zwickl, B., Hartman, P. B., Roarke, M. E., Burk, R. A., Fuhrer, J., Somogyi, K. A., Sepkowitz, K., Telzak, E. E., McAuliffe, V. J., Valentine, F. T., Vasquez, M., Merigan, T. C., Katzenstein, D., Fessell, J., Havlir, D. V., Richman, D. D., Spector, S. A., Kahn, J. O., Johnson, L., Coleman, R., Ho, M., McMahon, D., Pazin, G., Antoniskis, D., McNamara, B., Diamond, D., Collier, A. C., Paradise, M. A., Wald, A., DePaolis-Jones, A., Henry, K., Waskin, H. A., Hyslop, N. E. Jr, Mushatt, D. M., Zachary, J. A., Soeiro, R., Harris, C., Zingman, B., Giordano, M. F., Sledz, S., Murray, H. W., Carey, J. T., Davis, T. L., Bagby, B., Kessler, H. A., Murphy, R. I., Hirschtick, R. E., Cheeseman, S. H., Lai, K. K., Fairchild, P. G., Ehmann, W. C., Zurlo, J. J., Millard, R., Troiani, L., Heggen, A. A., van der Horst, C. M., McKinley, G. F., Grieco, M. H., Kolatch, B. R., Goldsmith, J. C., Gomperts, E. D., Woods, L. M., Grue, L., Mayjo, K., Becker, R. L., Jayaweera, D. T., Rolfe, L., Cole, J., Jermano, J.
(1995). Zidovudine Compared With Didanosine in Patients With Advanced HIV Type I Infection and Little or No Previous Experience With Zidovudine. Arch Intern Med
155: 961-974
[Abstract]
Bozzette, S. A., Kanouse, D. E., Berry, S., Duan, N., R, , Gocke, D. J., Marlowe, S. I., Pottage, J. C. Jr, Follansbee, S. E., Remick, S., Klimas, N., Jensen, P., Henry, D. H., Olson, R., Turner, P. A., Lalezari, J. P., Phair, J., Pollard, R., Pierce, P. F., Saravolatz, L. D., Cohen, S., Cate, T., Pegram, P. S., Spotkov, J., Carey, J. T., Perez, G., Pettinelli, C., DownesLeGuin, T., Hill, D., Edwards, C., Mazel, R., Hays, R., Stewart, A., Soo, W., Salgo, M., Anthony, M., Dixon, D., Myers, M.
(1995). Health Status and Function With Zidovudine or Zalcitabine as Initial Therapy for AIDS: A Randomized Controlled Trial. JAMA
273: 295-301
[Abstract]
Forseter, G., Joline, C., Wormser, G. P.
(1994). Tolerability, Safety, and Acceptability of Zidovudine Prophylaxis in Health Care Workers. Arch Intern Med
154: 2745-2749
[Abstract]
Duvic, M., Crane, M. M., Conant, M., Mahoney, S. E., Reveille, J. D., Lehrman, S. N.
(1994). Zidovudine Improves Psoriasis in Human Immunodeficiency Virus--Positive Males. Arch Dermatol
130: 447-451
[Abstract]
Lenderking, W. R., Gelber, R. D., Cotton, D. J., Cole, B. F., Goldhirsch, A., Volberding, P. A., Testa, M. A., The AIDS Clinical Trials Group,
(1994). Evaluation of the Quality of Life Associated with Zidovudine Treatment in Asymptomatic Human Immunodeficiency Virus Infection. NEJM
330: 738-743
[Abstract][Full Text]
Moore, R. D., Stanton, D., Gopalan, R., Chaisson, R. E.
(1994). Racial Differences in the Use of Drug Therapy for HIV Disease in an Urban Community. NEJM
330: 763-768
[Abstract][Full Text]
Hoover, D. R., Saah, A. J., Bacellar, H., Phair, J., Detels, R., Anderson, R., Kaslow, R. A., The Multicenter AIDS Cohort Study,
(1993). Clinical Manifestations of AIDS in the Era of Pneumocystis Prophylaxis. NEJM
329: 1922-1926
[Abstract][Full Text]
Phair, J. P., Abels, R. I., McNeill, M. V., Sullivan, D. J.
(1993). Recombinant Human Erythropoietin Treatment: Investigational New Drug Protocol for the Anemia of the Acquired Immunodeficiency Syndrome: Overall Results. Arch Intern Med
153: 2669-2675
[Abstract]
Sande, M. A., Carpenter, C. C. J., Cobbs, C. G., Holmes, K. K., Sanford, J. P., the National Institute of Allergy and Infectious D, , Sande, M. A., Carpenter, C. C. J., Cobbs, C. G., Coombs, R. W., Fleming, T. R., Holmes, K. K., Denison, R., Gail, M. H., Greaves, W. L., Hirsch, M. S., Luskin-Hawk, R., Mildvan, D., Nelson, C. A., Phair, J. P., Sanford, J. P., Schooley, R., Torres, R. G., Vazquez, R., Deyton, L., Jermano, J., Koziol, J., Pettinelli, C., Katz, D.
(1993). Antiretroviral Therapy for Adult HIV-lnfected Patients: Recommendations From a State-of-the-Art Conference. JAMA
270: 2583-2589
[Abstract]
Fox, N. W., McArthur, C. P.
(1993). Acquired Immunodeficiency Syndrome-- A Review and Update: History, Characteristics of Human Immunodeficiency Virus Infection, Its Replication, Biologic Factors, and Pathogenicity. Arch Fam Med
2: 1068-1077
[Abstract]
Hirsch, M. S., D'Aquila, R. T.
(1993). Therapy for Human Immunodeficiency Virus Infection. NEJM
328: 1686-1695
[Full Text]
Tabbara, I. A.
(1993). Erythropoietin: Biology and Clinical Applications. Arch Intern Med
153: 298-304
[Abstract]
Henry, D. H., Beall, G. N., Benson, C. A., Carey, J., Cone, L. A., Eron, L. J., Fiala, M., Fischl, M. A., Gabin, S. J., Gottlieb, M. S., Galpin, J. E., Groopman, J. E., Hooton, T. M., Jemsek, J. G., Levine, R. L., Miles, S. A., Rinehart, J. J., Rios, A., Robbins, W. J., Ruckdeschel, J. C., Smith, J. A., Spruance, S. L., Starrett, B., Toney, J., Zalusky, R., Abels, R. I., Bryant, E. C., Larholt, K. M., Sampson, A. R., Rudnick, S. A.
(1992). Recombinant Human Erythropoietin in the Treatment of Anemia Associated with Human Immunodeficiency Virus (HIV) Infection and Zidovudine Therapy: Overview of Four Clinical Trials. ANN INTERN MED
117: 739-748
[Abstract]
Koch, M. A., Volberding, P. A., Lagakos, S. W., Booth, D. K., Pettinelli, C., Myers, M. W.
(1992). Toxic Effects of Zidovudine in Asymptomatic Human Immunodeficiency Virus-Infected Individuals With CD4+ Cell Counts of 0.50x109/L or Less: Detailed and Updated Results From Protocol 019 of the AIDS Clinical Trials Group. Arch Intern Med
152: 2286-2292
[Abstract]
Chaisson, R. E., Keruly, J., Richman, D. D., Moore, R. D.
(1992). Pneumocystis Prophylaxis and Survival in Patients With Advanced Human Immunodeficiency Virus Infection Treated With Zidovudine. Arch Intern Med
152: 2009-2013
[Abstract]
McLeod, G. X., Hammer, S. M.
(1992). Zidovudine: Five Years Later. ANN INTERN MED
117: 487-501
[Abstract]
Gelber, R. D., Lenderking, W. R., Cotton, D. J., Cole, B. F., Fischl, M. A., Goldhirsch, A., Testa, M. A.
(1992). Quality-of-Life Evaluation in a Clinical Trial of Zidovudine Therapy in Patients with Mildly Symptomatic HIV Infection. ANN INTERN MED
116: 961-966
[Abstract]
Obuch, M. L., Baker, G., Roth, R. I., Yen, T. S. B., Jack, , Berger, T. G.
(1992). Selective Cutaneous Hyperpigmentation in Mice Following Zidovudine Administration. Arch Dermatol
128: 508-513
[Abstract]
Rabeneck, L., Viscoli, C. M., Horwitz, R. I.
(1992). Problems in the Conduct and Analysis of Randomized Clinical Trials: Are We Getting the Right Answers to the Wrong Questions?. Arch Intern Med
152: 507-512
[Abstract]
Wong, R. J.
(1992). The Pharmacological Treatment of Human Immunodeficiency Virus Infection. Journal of Pharmacy Practice
5: 121-130
[Abstract]
Meng, T.-C., Fischl, M. A., Boota, A. M., Spector, S. A., Bennett, D., Bassiakos, Y., Lai, S., Wright, B., Richman, D. D.
(1992). Combination Therapy with Zidovudine and Dideoxycytidine in Patients with Advanced Human Immunodeficiency Virus Infection: A Phase I/II Study. ANN INTERN MED
116: 13-20
[Abstract]
Dannemann, B., McCutchan, J. A., Israelski, D., Antoniskis, D., Leport, C., Luft, B., Nussbaum, J., Clumeck, N., Morlat, P., Chiu, J., Vilde, J.-L., Orellana, M., Feigal, D., Bartok, A., Heseltine, P., Leedom, J., Remington, J.
(1992). Treatment of Toxoplasmic Encephalitis in Patients with AIDS: A Randomized Trial Comparing Pyrimethamine plus Clindamycin to Pyrimethamine plus Sulfadiazine. ANN INTERN MED
116: 33-43
[Abstract]
Allen, U. D., Guerriere, M., Read, S. E., Detsky, A. S.
(1991). Percutaneous Injuries Among Health Care Workers: The Real Value of Human Immunodeficiency Virus Testing of 'Donor' Blood. Arch Intern Med
151: 2033-2040
[Abstract]
Barnett, J. H., Gilson, I.
(1991). Zidovudine-Related Thrombocytopenia Simulating Rapid Growth of Kaposi's Sarcoma. Arch Dermatol
127: 1068-1069
[Abstract]
Sattler, F. R., Ko, R., Antoniskis, D., Shields, M., Cohen, J., Nicoloff, J., Leedom, J., Koda, R.
(1991). Acetaminophen Does Not Impair Clearance of Zidovudine. ANN INTERN MED
114: 937-940
[Abstract]
Skelton, W. P. III, Skelton, N. K.
(1991). Observations Concerning the Use of Zidovudine in an Outpatient Setting. Arch Intern Med
151: 1238-1239
[Abstract]
Moore, R. D., Creagh-Kirk, T., Keruly, J., Link, G., Wang, M.-C., Richman, D., Chaisson, R. E., Zidovudine Epidemiology Study Group,
(1991). Long-term Safety and Efficacy of Zidovudine in Patients With Advanced Human Immunodeficiency Virus Disease. Arch Intern Med
151: 981-986
[Abstract]
Colson, E. R., Horwitz, R. I., Bia, F. J., Viscoli, C. M.
(1991). Zidovudine (AZT) for Treatment of Patients Infected With Human Immunodeficiency Virus Type 1: An Evaluation of Effectiveness in Clinical Practice. Arch Intern Med
151: 709-713
[Abstract]
Merluzzi, V., Hargrave, K., Labadia, M, Grozinger, K, Skoog, M, Wu, J., Shih, C., Eckner, K, Hattox, S, Adams, J, et, al.
(1990). Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. Science
250: 1411-1413
[Abstract]
Broder, S., Mitsuya, H., Yarchoan, R., Pavlakis, G. N.
(1990). Antiretroviral Therapy in AIDS. ANN INTERN MED
113: 604-618
[Abstract]
Mitsuya, H, Yarchoan, R, Broder, S
(1990). Molecular targets for AIDS therapy. Science
249: 1533-1544
[Abstract]
Hochster, H., Dieterich, D., Bozzette, S., Reichman, R. C., Connor, J. D., Liebes, L., Sonke, R. L., Spector, S. A., Valentine, F., Pettinelli, C., Richman, D. D.
(1990). Toxicity of Combined Ganciclovir and Zidovudine for Cytomegalovirus Disease Associated with AIDS: An AIDS Clinical Trials Group Study. ANN INTERN MED
113: 111-117
[Abstract]
Ruedy, J., Schechter, M., Montaner, J. S. G.
(1990). Zidovudine for Early Human Immunodeficiency Virus (HIV) Infection: Who, When, and How?. ANN INTERN MED
112: 721-723
[Abstract]
Fischl, M. A., Richman, D. D., Hansen, N., Collier, A. C., Carey, J. T., Para, M. F., Hardy, W. D., Dolin, R., Powderly, W. G., Allan, J. D., Wong, B., Merigan, T. C., McAuliffe, V. J., Hyslop, N. E., Rhame, F. S., Balfour, H. H. Jr., Spector, S. A., Volberding, P., Pettinelli, C., Anderson, J., AIDS Clinical Trials Group,
(1990). The Safety and Efficacy of Zidovudine (AZT) in the Treatment of Subjects with Mildly Symptomatic Human Immunodeficiency Virus Type 1 (HIV) Infection: A Double-Blind, Placebo-Controlled Trial. ANN INTERN MED
112: 727-737
[Abstract]
Miles, S. A., Wang, H., Cortes, E., Carden, J., Marcus, S., Mitsuyasu, R. T.
(1990). Beta-Interferon Therapy in Patients with Poor-Prognosis Kaposi Sarcoma Related to the Acquired Immunodeficiency Syndrome (AIDS) A Phase II Trial with Preliminary Evidence of Antiviral Activity and Low Incidence of Opportunistic Infections. ANN INTERN MED
112: 582-589
[Abstract]
Schooley, R. T., Merigan, T. C., Gaut, P., Hirsch, M. S., Holodniy, M., Flynn, T., Liu, S., Byington, R. E., Henochowicz, S., Gubish, E., Spriggs, D., Kufe, D., Schindler, J., Dawson, A., Thomas, D., Hanson, D. G., Letwin, B., Liu, T., Gulinello, J., Kennedy, S., Fisher, R., Ho, D. D.
(1990). Recombinant Soluble CD4 Therapy in Patients with the Acquired Immunodeficiency Syndrome (AIDS) and AIDS-Related Complex: A Phase I-II Escalating Dosage Trial. ANN INTERN MED
112: 247-253
[Abstract]
McQuade, T., Tomasselli, A., Liu, L, Karacostas, V, Moss, B, Sawyer, T., Heinrikson, R., Tarpley, W.
(1990). A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation. Science
247: 454-456
[Abstract]
Herrero, C., Bassas, S., Azon, A., Mascaro, J. M., Miro, J.
(1990). Acquired Immunodeficiency Syndrome in a Patient Affected by Hereditary Coproporphyria: Safety of Zidovudine Treatment. Arch Dermatol
126: 122-123
[Abstract]
Fischl, M. A., Richman, D. D., Causey, D. M., Grieco, M. H., Bryson, Y., Mildvan, D., Laskin, O. L., Groopman, J. E., Volberding, P. A., Schooley, R. T., Jackson, G. G., Durack, D. T., Andrews, J. C., Nusinoff-Lehrman, S., Barry, D. W.
(1989). Prolonged Zidovudine Therapy in Patients With AIDS and Advanced AIDS-Related Complex. JAMA
262: 2405-2410
[Abstract]
Arno, P. S., Shenson, D., Siegel, N. F., Franks, P., Lee, P. R.
(1989). Economic and Policy Implications of Early Intervention in HIV Disease. JAMA
262: 1493-1498
[Abstract]
Bendick, C., Rasokat, H., Steigleder, G. K.
(1989). Azidothymidine-Induced Hyperpigmentation of Skin and Nails. Arch Dermatol
125: 1285-1286
[Abstract]
Kovacs, J. A., Deyton, L., Davey, R., Falloon, J., Zunich, K., Lee, D., Metcalf, J. A., Bigley, J. W., Sawyer, L. A., Zoon, K. C., Masur, H., Fauci, A. S., Clifford Lane, H.
(1989). Combined Zidovudine and Interferon-{alpha} Therapy in Patients with Kaposi Sarcoma and the Acquired Immunodeficiency Syndrome (AIDS). ANN INTERN MED
111: 280-287
[Abstract]
Yarchoan, R, Mitsuya, H, Thomas, R., Pluda, J., Hartman, N., Perno, C., Marczyk, K., Allain, J., Johns, D., Broder, S
(1989). In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosine. Science
245: 412-415
[Abstract]
Lane, H. C., Falloon, J., Walker, R. E., Deyton, L., Kovacs, J. A., Masur, H., Banks, S., Kirk, L. E., Baseler, M. W., Salzman, N. P., Fauci, A. S.
(1989). Zidovudine in Patients with Human Immunodeficiency Virus (HIV) Infection and Kaposi Sarcoma: A Phase II Randomized, Placebo-Controlled Trial. ANN INTERN MED
111: 41-50
[Abstract]
Spivak, J. L., Barnes, D. C., Fuchs, E., Quinn, T. C.
(1989). Serum Immunoreactive Erythropoietin in HIV-Infected Patients. JAMA
261: 3104-3107
[Abstract]
Guyer, D. R., Jabs, D. A., Brant, A. M., Beschorner, W. E., Green, W. R.
(1989). Regression of Cytomegalovirus Retinitis With Zidovudine: A Clinicopathologic Correlation. Arch Ophthalmol
107: 868-874
[Abstract]
McKINSEY, D. S., DURFEE, D., KURTIN, PAULJ.
(1989). Megaloblastic Pancytopenia Associated With Dapsone and Trimethoprim Treatment of Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency Syndrome. Arch Intern Med
149: 965-965
[Abstract]
Larder, B., Darby, G, Richman, D.
(1989). HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science
243: 1731-1734
[Abstract]
Oksenhendler, E., Bierling, P., Ferchal, F., Clauvel, J.-P., Seligmann, M.
(1989). Zidovudine for Thrombocytopenic Purpura Related to Human Immunodeficiency Virus (HIV) Infection. ANN INTERN MED
110: 365-368
[Abstract]
Balis, F. M., Pizzo, P. A., Murphy, R. F., Eddy, J., Jarosinski, P. F., Falloon, J., Broder, S., Poplack, D. G.
(1989). The Pharmacokinetics of Zidovudine Administered by Continuous Infusion in Children. ANN INTERN MED
110: 279-285
[Abstract]
Wainberg, M. A., Falutz, J., Fanning, M., Gill, J., Gelmon, K., Montaner, J. S. G., O'Shaughnessy, M., Tsoukas, C., Ruedy, J.
(1989). Cessation of Zidovudine Therapy May Lead to Increased Replication of HIV-1. JAMA
261: 865-866
[Abstract]
Abrams, D. I., Kuno, S., Wong, R., Jeffords, K., Nash, M., Molaghan, J.B., Gorter, R., Ueno, R.
(1989). Oral Dextran Sulfate (UAOO1) in the Treatment of the Acquired Immunodeficiency Syndrome (AIDS) and AIDS-Related Complex. ANN INTERN MED
110: 183-188
[Abstract]
Hirsch, M. S.
(1989). The Rocky Road to Effective Treatment of Human Immunodeficiency Virus (HIV) Infection. ANN INTERN MED
110: 1-3
[Abstract]
Jabs, D. A., Enger, C., Bartlett, J. G.
(1989). Cytomegalovirus Retinitis and Acquired Immunodeficiency Syndrome. Arch Ophthalmol
107: 75-80
[Abstract]
Dubin, G., Braffman, M. N.
(1989). Zidoyudine-Induced Hepatotoxicity. ANN INTERN MED
110: 85-86
[Abstract]
O'Dowd, M. A., McKegney, F. P.
(1988). Manic Syndrome Associated With Zidovudine. JAMA
260: 3587-3587
[Abstract]
Pottage, J. C. Jr, Benson, C. A., Spear, J. B., Landay, A. L., Kessler, H. A.
(1988). Treatment of Human Immunodeficiency Virus--Related Thrombocytopenia With Zidovudine. JAMA
260: 3045-3048
[Abstract]
Bartlett, J. A.
(1988). HIV Therapeutics: An Emerging Science. JAMA
260: 3051-3052
[Abstract]
Previous
